Providing independent clinical excellence since 2005
At SCVC we offer sophisticated healthscreening and expert medical care, combining decades of experience with the latest technologies for early diagnosis, investigation, prevention and treatment of cardiovascular and cancer issues.
Join our mailing list to be notified about new blog stories and educational webinars for GPs and patients.
Our newly refurbished clinic provides direct access to a whole team that is passionate about healthcare delivery.
Our mission is to provide all of our patients with the best available care and the latest information about modern diagnostic and health screening technology in order for everyone to be able to make informed choices and become the centre of their own healthcare.
Experienced consultants who operate across London, Surrey and Hampshire join our faculty to use its unrivalled facilities. Consultants can refer their patients from anywhere, using electronic referral systems, and can view their patient’s results and images from their private rooms, home or, for NHS patients having private tests, their NHS clinics. They can review their patient immediately after a virtual coronary angiogram in our one stop clinics. These unique arrangements are simply not available from any other private hospital providers.
Our friendly administration team are on hand to help you guide your health care pathway at SCVC.
Get started now by completing our no-obligation enquiry form for our free pre-consultation. It only takes 5 minutes.
Body recomposition focuses on reducing visceral fat while preserving muscle mass, offering superior cardiovascular protection compared to traditional weight loss. This approach proves particularly valuable for patients with coronary disease, those starting GLP-1 therapy, and adults over 60 facing age-related muscle loss.
Patients with a low CHA₂DS₂-VASc score are often considered low risk for stroke. However, around cardioversion, this changes. Atrial paresis following restoration of sinus rhythm creates a temporary high-risk period for clot formation, particularly after AF lasting more than 24 hours, making short-term anticoagulation essential even in younger patients.
A single episode of atrial fibrillation in patients with a CHA₂DS₂-VASc score ≥2 often leads to a recommendation for lifelong anticoagulation. But is this always necessary? This article explores when exceptions may be reasonable, the importance of rhythm monitoring, and how shared decision-making can guide personalised, safe stroke prevention strategies.
